Highlights

Highlights

  • 12.02.2026 – 11:00

    SolidarMed

    SolidarMed: High blood pressure: trained laypeople improve healthcare in rural Africa

    High blood pressure: trained laypeople improve healthcare in rural Africa

    Basel (ots) - In rural regions of Africa, high blood pressure often goes untreated because health centres are far away and there is a shortage of health professionals. A study by the University of Basel and SolidarMed in Lesotho shows that, with the help of a tablet app, villagers who have received training achieve better blood pressure control in their village community compared to normal treatment in healthcare facilities. The results provide the first robust data for an approach that could significantly improve access to blood pressure treatment in underserved regions. High blood pressure ...

Neueste Storys

Filtern
  • 26.09.2017 – 13:02

    Medicago

    Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine

    Québec City (ots/PRNewswire) - The first plant-based seasonal flu vaccine candidate reaches final clinical stage Medicago, a Canadian biopharmaceutical company and leader in the development and production of plant-based vaccines and therapeutics, is proud to announce the start of a Phase 3 efficacy study for its seasonal quadrivalent influenza vaccine (QIV) candidate. ...

  • 26.09.2017 – 11:01

    World Innovation Summit for Education (WISE)

    Six Winners of the 2017 Wise Awards Announced

    Doha, Qatar (ots/PRNewswire) - The WISE Awards Recognize Projects for Innovative Solutions to Urgent Education Challenges The World Innovation Summit for Education (WISE), a leading international initiative for innovation and collaboration in education, has named the six winning projects of the 2017 WISE Awards, recognizing and promoting innovative education initiatives around the world. The 2017 WISE Awards winners: 42 ...

  • 21.09.2017 – 09:13

    Merck Healthcare Germany

    European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

    Darmstadt, Germany, and New York, Usa (ots/PRNewswire) - Not intended for US, Canadian and UK-based media - First approved immunotherapy for rare and aggressive skin cancer in the European Union, with initial launches planned in Germany and the UK - Builds on Bavencio's previous accelerated approvals in the US and recent approval in Switzerland - Approval is based on ...

  • 20.09.2017 – 22:16

    Accuray Europe

    Accuray Showcases CyberKnife® and Radixact(TM) Systems at ASTRO 2017

    Sunnyvale, California (ots/PRNewswire) - Accuray Incorporated (NASDAQ: ARAY) announced today that data and first-hand experience with its advanced CyberKnife® and Radixact(TM) Systems (http://www.accuray.com/product-overview) , and unique software solutions, will be shared by leading radiation oncology practitioners at the 2017 ASTRO (American Society for Radiation Oncology) Annual Meeting in San Diego, California from ...

  • 20.09.2017 – 19:01

    deCODE genetics

    deCODE Study Reveals an Ancient Achilles Heel in the Human Genome

    Reykjavik, Iceland (ots/PRNewswire) - - The generation of new mutations is a key driver of evolution but also of susceptibility to rare diseases - Fathers pass on four times as many new mutations as mothers do, but the maternal contribution is particularly strong in 10% of the genome that is prone to double-strand breaks in the helix structure of DNA - These regions have been mutational hotspots for a very long time, and ...